A tumor control probability model for anal squamous cell carcinoma

A tumor control probability model for anal squamous cell carcinoma

<p><strong>Background and purpose</strong> A recent update of the RTOG 9811, reported differing relapse rates for early and late anal squamous cell carcinoma following chemoradiotherapy (CRT). There may be a role for dose-individualization, however the dose–response relationship fo...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Muirhead, R, Partridge, M, Hawkins, M
Formaat:	Journal article
Gepubliceerd in:	Elsevier 2015

Gelijkaardige items

WE-AB-202-10: Modelling individual tumor-specific control probability for hypoxia in rectal cancer.
door: Warren, S, et al.
Gepubliceerd in: (2016)

Is there a role for a biological boost in squamous cell anal cancer?
door: Sabbagh, A, et al.
Gepubliceerd in: (2018)

Is there a role for an FDG derived biological boost in squamous cell anal cancer?
door: Sabbagh, A, et al.
Gepubliceerd in: (2018)

Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma
door: Bluemke, E, et al.
Gepubliceerd in: (2020)

Anal Intraepithelial Neoplasia: Precursor of Anal Squamous Cell Carcinoma
door: Taku Sakamoto, et al.
Gepubliceerd in: (2022-04-01)

Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma
door: Emma Bluemke, et al.
Gepubliceerd in: (2020-05-01)

Is there a role for an 18F-fluorodeoxyglucose-derived biological boost in squamous cell anal cancer?
door: Sabbagh, A, et al.
Gepubliceerd in: (2018)

Submucosal variant anal squamous cell carcinoma
door: MD Joseph Terlizzi, et al.
Gepubliceerd in: (2018-06-01)

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
door: Oblak Irena, et al.
Gepubliceerd in: (2016-02-01)

Unexpected Anal Squamous Cells Carcinoma after Open Hemorrhoidectomy
door: Navarra Luca, et al.
Gepubliceerd in: (2015-01-01)

Editorial: New understandings and research in anal squamous cell carcinoma
door: Stefano Kim, et al.
Gepubliceerd in: (2023-01-01)

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
door: D. Martin, et al.
Gepubliceerd in: (2024-04-01)

ORGAN-SPARING TREATMENT IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL
door: Yu. A. Barsukov, et al.
Gepubliceerd in: (2015-02-01)

Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model
door: Lin-Lin Bu, et al.
Gepubliceerd in: (2017-07-01)

Trends in utilization of first‐line palliative treatments for anal squamous cell carcinoma
door: Srinidhi J. Radhakrishnan, et al.
Gepubliceerd in: (2023-02-01)

Electron beam radiotherapy for the management of squamous cell carcinoma of the anal margin
door: Lars Fokdal, et al.
Gepubliceerd in: (2024-08-01)

Recommendations for the management of squamous cell carcinoma of the anal canal and perianal region
door: Franc Anderluh, et al.
Gepubliceerd in: (2022-11-01)

Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
door: Lucía Trilla-Fuertes, et al.
Gepubliceerd in: (2020-07-01)

Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice
door: Morgan T. Walcheck, et al.
Gepubliceerd in: (2021-01-01)

Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma
door: Daniel R. Principe, et al.
Gepubliceerd in: (2022-06-01)

Oncologic outcomes of squamous cell carcinoma of the anal canal after chemoradiation therapy
door: Dae Ro Lim, et al.
Gepubliceerd in: (2016-06-01)

Endoscopic submucosal dissection to treat squamous cell carcinoma in situ of the anal canal
door: Michael Lajin, MD, et al.
Gepubliceerd in: (2022-06-01)

Interobserver variability in clinical target volume delineation in anal squamous cell carcinoma
door: Kyung Su Kim, et al.
Gepubliceerd in: (2021-02-01)

Development of Cerebral Metastasis after Medical and Surgical Treatment of Anal Squamous Cell Carcinoma
door: Andrew Austin Gassman, et al.
Gepubliceerd in: (2012-01-01)

Personalized dose escalation in anal cancer
door: Robinson, M, et al.
Gepubliceerd in: (2016)

Radiation therapy of recurrent anal squamous cell carcinoma in-situ: a case report
door: Noone Robert, et al.
Gepubliceerd in: (2010-02-01)

THE USE OF PACLITAXEL IN CHEMORADIOTHERAPY OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL: A PILOT STUDY
door: S. S. Gordeev, et al.
Gepubliceerd in: (2017-01-01)

Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer
door: Robinson, M, et al.
Gepubliceerd in: (2015)

Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis
door: Krupa S. Jani, et al.
Gepubliceerd in: (2021-06-01)

Chemotherapeutic Response and Survival for Patients With an Anal Squamous Cell Carcinoma and Low Hemoglobin Levels
door: Ali Zain Naqvi, et al.
Gepubliceerd in: (2018-12-01)

Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma
door: Athénaïs Grave, et al.
Gepubliceerd in: (2022-07-01)

Neuroendocrine tumor and squamous cell carcinoma arising in a tailgut cyst with features of anal canal: Report of a case and review of the literature
door: Momoko Takizawa, et al.
Gepubliceerd in: (2021-11-01)

Radiomics and Machine Learning in Anal Squamous Cell Carcinoma: A New Step for Personalized Medicine?
door: Nicolas Giraud, et al.
Gepubliceerd in: (2020-03-01)

Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT)
door: Durrant, L, et al.
Gepubliceerd in: (2016)

Patterns and predictors of relapse following radical chemoradiation therapy delivered using intensity modulated radiation therapy with a simultaneous integrated boost in anal squamous cell carcinoma
door: Shakir, R, et al.
Gepubliceerd in: (2019)

Retrospective observational real-world data on squamous cell carcinoma of the anal canal from South India
door: Nikhil K Haridas, et al.
Gepubliceerd in: (2023-01-01)

Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience
door: Krishan R. Jethwa, et al.
Gepubliceerd in: (2021-05-01)

Tumor Control Probability Modeling for Radiation Therapy of Keratinocyte Carcinoma
door: Phillip Prior, et al.
Gepubliceerd in: (2021-05-01)

Surgery, chemoradiotherapy, or chemoradiation plus immunotherapy: Treatment strategies for nonmetastatic anal squamous cell carcinoma
door: Fang He, et al.
Gepubliceerd in: (2024-12-01)

Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
door: Angélique Saint, et al.
Gepubliceerd in: (2019-11-01)